Literature DB >> 12687908

Dynamic susceptibility contrast MRI of gliomas.

Hannu J Aronen1, Jussi Perkiö.   

Abstract

Dynamic susceptibility contrast imaging has proven to be useful in brain tumor studies, and it provides additional information on tumor characteristics based on the microvascular structure of gliomas. The cerebral blood volume maps can be used to noninvasively grade gliomas, to determine optimal biopsy sites, to separate radiation necrosis from tumor regrowth, and to plan and follow irradiation, chemo- and antiangiogenic therapy. Besides of cerebral blood volume mapping, dynamic susceptibility contrast imaging sets also contain information about the flow and permeability properties of the tumor microvascular system. When combined with the conventional MRI, dynamic susceptibility contrast techniques offer important functional information about the biology of gliomas in a cost-effective way.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12687908     DOI: 10.1016/s1052-5149(02)00026-6

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  32 in total

1.  Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.

Authors:  Stella Blasel; Kea Franz; Hanns Ackermann; Stefan Weidauer; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurooncol       Date:  2010-10-07       Impact factor: 4.130

2.  MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas.

Authors:  Chih-Chun Wu; Rajan Jain; Lucidio Neto; Seema Patel; Laila M Poisson; Jonathan Serrano; Victor Ng; Sohil H Patel; Dimitris G Placantonakis; David Zagzag; John Golfinos; Andrew S Chi; Matija Snuderl
Journal:  Neuroradiology       Date:  2019-05-27       Impact factor: 2.804

3.  Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

Authors:  Mark E Mullins; Glenn D Barest; Pamela W Schaefer; Fred H Hochberg; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging.

Authors:  Bei Ding; Hua Wei Ling; Ke Min Chen; Hong Jiang; Yan Bo Zhu
Journal:  Neuroradiology       Date:  2006-08-26       Impact factor: 2.804

5.  Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study.

Authors:  C P Geer; J Simonds; A Anvery; M Y Chen; J H Burdette; M E Zapadka; T L Ellis; S B Tatter; G J Lesser; M D Chan; K P McMullen; A J Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

6.  Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

Authors:  Tufail F Patankar; Hamied A Haroon; Samantha J Mills; Danielle Balériaux; David L Buckley; Geoff J M Parker; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

7.  Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.

Authors:  Leor Zach; David Guez; David Last; Dianne Daniels; Yuval Grober; Ouzi Nissim; Chen Hoffmann; Dvora Nass; Alisa Talianski; Roberto Spiegelmann; Galia Tsarfaty; Sharona Salomon; Moshe Hadani; Andrew Kanner; Deborah T Blumenthal; Felix Bukstein; Michal Yalon; Jacob Zauberman; Jonathan Roth; Yigal Shoshan; Evgeniya Fridman; Marc Wygoda; Dror Limon; Tzahala Tzuk; Zvi R Cohen; Yael Mardor
Journal:  Neuro Oncol       Date:  2014-11-30       Impact factor: 12.300

8.  Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Meng Law; Robert J Young; James S Babb; Nicole Peccerelli; Sophie Chheang; Michael L Gruber; Douglas C Miller; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  Radiology       Date:  2008-03-18       Impact factor: 11.105

Review 9.  Post-treatment imaging changes in primary brain tumors.

Authors:  Barbara J O'Brien; Rivka R Colen
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

Review 10.  Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.

Authors:  George A Alexiou; Spyridon Tsiouris; Athanasios P Kyritsis; Spyridon Voulgaris; Maria I Argyropoulou; Andreas D Fotopoulos
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.